Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA). Lee JB, Choi SJ, Shim HS, Park BJ, et al. J Thorac Oncol 2024 Dec 26:S1556-0864(24)02544.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee JB, Choi SJ, Shim HS, Park BJ, et al. Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA). J Thorac Oncol 2024 Dec 26:S1556-0864(24)02544.
PMID: 39732365